logo
logo
Sign in

Prostate Cancer Diagnostics Market Size, Company Revenue Share, Key Drivers, and Trend Analysis, 2020–2027

avatar
jhon tanison

The rising incidence of prostate cancer is one of the significant factors influencing the growth of the diagnostic procedures for the disease.

Market Size – USD 2,801.7 Million in 2019, Market Growth - CAGR of 12.3%, Market Trends – Increasing awareness about cancer diagnosis at an early stage.

The global prostate cancer diagnostics market is forecasted to reach USD 7,112.2 Million by 2027, according to a new report by Reports and Data. The prostate cancer diagnostics market is observing demand attributed to the rising incidence of prostate cancer. It is the most common cause of death occurring as a result of cancer in American men. It has been found that nearly 1 out of 41 men die of prostate cancer. According to recent estimations, around 33,330 men will die of the disease in the year 2020.

Increasing awareness about cancer diagnosis at an early stage is a significant factor driving the market growth. A majority of prostate cancers or about 90.0% cases are detected when the disease is in the prostate gland and the nearby organs, and for such cases, the 5-year survival rate is about 100.0%, whereas the 5-year survival rate for the cases in which the disease has spread to other body parts is 31.0%.

 

Key companies operating in the market and profiled in the report include:

Abbott Laboratories, Siemens Healthineers, F. Hoffman La Roche Ltd., Danaher Corporation, Agilent Technologies, Myriad Genetics Inc., Becton, Dickinson, and Company, Diasorin SPA, Genomic Health, and Beckman Coulter Inc.

 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3709

 

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Prostate Cancer Diagnostics market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

 

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3709

 

The Prostate Cancer Diagnostics market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

 

Segments Covered in the report

Prostate Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

  • Acinar Adenocarcinoma
  • Ductal Adenocarcinoma
  • Transitional Cell (or Urothelial) Cancer
  • Squamous Cell Cancer
  • Small Cell Prostate Cancer
  • Others

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Preliminary Tests
  • Confirmatory Tests
    1. PCA3
    2. Transrectal Ultrasound
    3. Biopsy

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others

 

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA
    •  

To know more about the report @ https://www.reportsanddata.com/report-detail/prostate-cancer-diagnostics-market

 

Furthermore, it consists information about individual segment of the Prostate Cancer Diagnostics market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

 

Key Benefits of the Report:

  • Comprehensive overview of the changing dynamics of competitive landscape
  • Detail oriented futuristic prospects of factors driving and restraining growth of the market
  • Valuable insights on key market growth driving trends and monetary competence in the forecast period
  • Strategic recommendations to key players and new entrants to overcome barriers and challenges in the market
  • Revenue forecasts for the period of 2021-2027

 

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3709

 

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

Browse More Reports:

Nutraceutical Products Market Size

Oilfield Equipment Market Share

Ankylosing Spondylitis (AS) Market Size

Bovine Blood Plasma Derivatives Market

 

 

collect
0
avatar
jhon tanison
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more